The role of y-interferon in the pathogenesis of enteropathies with an immunological basis such as coeliac disease, is unclear. y-interferon immunoreactive lymphocytes were quantified in jejunal biopsies from patients with coeliac disease and from normal controls. In coeliac disease, there was an apparent decrease in the percentage of both intraepithelial (3.5% v 13.5%) and lamina propria 
Gamma-interferon plays a critical role in protective immune responses because of its ability to stimulate the effector functions of several nonspecific cells such as macrophages and natural killer cells, and to enhance the expression of class II major histocompatibility complex antigens on antigen presenting cells and other tissue cells.' y-interferon has also been shown to modulate the proliferation and function of tissue cells from a variety of organs, including thyroid, pancreas, brain bone, and kidney. Therefore, this T lymphocyte product has been implicated as an important mediator of pathology in a variety of autoimmune and inflammatory conditions. Gamma-interferon may play a similar role in enteropathies with an immunological basis such as coeliac disease, and this has been supported by several recent findings. Enhanced expression of class II major histocompatibility complex antigens is a characteristic feature of coeliac disease23 and y-interferon is a potent inducer of major histocompatibility complex expression by human enterocytes in vitro. 4 Furthermore, the similar form of enteropathy which occurs during a graft-versus-host reaction in experimental animals can be prevented by in vivo administration of anti y-interferon monoclonal antibodies. 5 There is no direct evidence, however, that y-interferon plays a pathogenetic role in clinical enteropathy. In addition, it is not known whether y-interferon producing cells are present within the intestinal mucosa or if the production of y-interferon correlates with pathological changes in the epithelium. In this report, we have attempted to define the role of y-interferon in intestinal immunopathology by enumerating y-interferon producing lymphocytes in paraffin embedded sections of normal and coeliac disease intestine using an immunohistochemical technique. In parallel, we have correlated the number of y-interferon secreting cells with the epithelial expression of class II major histocompatibility complex antigens and have examined the effects of treatment with a gluten free diet.
Methods

JEJUNAL BIOPSIES
Formol saline fixed, paraffin embedded Crosby capsule jejunal biopsy specimens were collected by reviewing the archives of the Royal Infirmary Pathology Department over a five year period.
Thirty six biopsy specimens from 34 adult patients with coeliac disease were retrieved and these were classified into four groups as described below and in the Table. Group 1 comprised biopsies from patients with untreated coeliac disease (n= 19 Class II major histocompatibility complex antigen could be detected on the epithelial cells of all control cases. This was usually at low concentrations and was found predominantly in the upper two-thirds of the villi, with crypt epithelial cells being entirely negative. In coeliac disease, patients with abnormal histology have increased intensity of epithelial staining which in some cases now extended into the crypts. In patients whose mucosa had returned to normal after a gluten free diet, the intensity and extent of class II major histocompatibility complex expression were similar to that seen in control biopsies.
GAMMA-INTERFERON EXPRESSING LYMPHOCYTES IN NORMAL MUCOSA
Gamma-interferon expressing cells which all had the morphology of small lymphocytes, were readily detected both in the lamina propria and epithelium of the normal controls (Fig 1) . Indeed, the median number of y-interferon expressing cells in the lamina propria was almost half the total of leucocytes identified by the anti-CD45 antibody (range: 20-88%), while 13.5% of normal intraepithelial lymphocytes were positive for y-interferon (range: 2-35%). The staining was specific for y-interferon as it could be blocked by preincubating the antibody with recombinant human y-interferon.8
GAMMA-INTERFERON EXPRESSION BY INFILTRATING LYMPHOCYTES IN COELIAC DISEASE
As anticipated, patients with untreated coeliac disease had an increased density of CD45 + intra epithelial lymphocytes compared with disease controls (although this did not reach statistical significance), as did patients on a gluten free diet with abnormal histology (Table) . The density of lamina propria lymphocytes was somewhat increased in most groups of coeliac patients, but this showed considerable variability and did not exhibit the same relationship to dietary status (Table) .
Despite the increased total intra epithelial lymphocyte count, there was no corresponding increase in the absolute number of y-interferon expressing intra epithelial lymphocytes in coeliac patients with abnormal histology (Table, Fig 2) . As a result, the proportion of intra epithelial lymphocytes which expressed y-interferon was considerably reduced in these patients, compared with disease controls (Fig 3) . Although this did not attain statistical significance in individual groups, the proportion ofy-interferon expressing intra epithelial lymphocytes in untreated coeliacs was only 25% of the value found in normal mucosa and a similar reduction was found in other groups with mucosal pathology (Fig 3) . Furthermore, in those patients with resolution of pathology on a gluten free diet, the proportion of y-interferon expressing intra epithelial lymphocytes returned towards normal concentrations, indicating a true disease related effect (Fig 2) . The proportion of y-interferon expressing lymphocytes in the lamina propria of coeliac patients showed an identical pattern, with reduced levels (33%-43% of control values) in all groups of patients with abnormal histology and a return towards normal during a successful gluten free diet (Table , Fig 4) .
Discussion
Our study is the first to enumerate y-interferon producing cells in sections of human intestine and the results show that a remarkably large proportion of lymphocytes in the lamina propria and epithelium of normal small bowel mucosa contain y-interferon. As y-interferon is produced primarily by activated T cells, these findings confirm other impressions that intestinal T lymphocytes are in a constant state of immune activation, with a large proportion of human mucosal T cells expressing memory cell markers'0" associated with the capacity to produce large amounts of a range of different cytokines. 12 Our results contrast with recent reports which found few y-interferon secreting cells in normal human intestinal mucosa, ' We were unable to analyse the phenotype of the lymphocytes producing y-interferon because the specimens had been fixed in formalin. CD4+ T cells are normally held to be the principal source of this mediator' and the higher proportion of y-interferon producing cells we found among lamina propria lymphocytes compared with intra epithelial lymphocytes is consistent with the relative numbers of CD4+ T cells in these sites.' Nevertheless, CD8+ T cells from mouse intestine can produce significant amounts ofy-interferon in vitro,'5 emphasising the need to determine the phenotype ofy-interferon producing lymphocytes directly. Furthermore, direct confirmation is needed that the cytoplasmic y-interferon we detected was being synthesised actively by these cells, using appropriate techniques to assess the presence of cytoplasmic messenger ribonucleic acid.
An unexpected finding from our study was that, in untreated coeliac disease, the proportion of y-interferon positive cells in the lamina propria and epithelium was reduced compared with normal mucosa. This was despite the fact that our patients had the expected increases in intra epithelial lymphocyte count, as well as increased expression of epithelial class II major histocompatibility complex antigens. The proportional reduction in y-interferon production appeared to be truly disease related as the numbers of y-interferon positive intra epithelial lymphocytes and lamina propria lymphocytes returned towards normal on a gluten free diet, in parallel with the improvement in mucosal pathology and in other indices of immunopathology. In addition, all parameters remained abnormal in patients not adhering to their gluten free diet, or in whom villous atrophy had not resolved.
The reduced concentrations of y-interferon were surprising in view of its involvement in other forms of immunopathology'$20 and of the recent finding that there is increased spontaneous production of y-interferon by lamina propria cells in Crohn's disease.'4 There is also experimental evidence implicating y-interferon in the epithelial manifestations of immunologically mediated enteropathy,5 while coeliac disease is associated with the presence of increased numbers of activated T lymphocytes." 21 One possible reason for these findings is that increased synthesis of y-interferon does occur in coeliac disease, but that this is accompanied by more rapid secretion from the cell. As a result there could be a decrease in stainable immunoreactive product in the cell. A similar phenomenon seems to occur in Crohn's disease,)' but direct confirmation of this idea would need examination of messenger ribonucleic acid concentrations.
We consider it more likely that increased numbers of non-y-interferon producing lymphocytes infiltrate the mucosa in coeliac disease. This is suggested by our observation that the absolute number of y-interferon positive cells remains close to normal in coeliac disease but that the total number of intra epithelial lymphocytes and lamina propria lymphocytes is increased. Therefore, it may be these additional lymphocytes which are responsible for the enteropathy of coeliac disease and y-interferon 
